The 7 Most Heavily Shorted NYSE Stocks
Only one of the seven stocks traded on the New York Stock Exchange with the largest number of shares held short as of October 15 experienced a decline in short interest.
Only one of the seven stocks traded on the New York Stock Exchange with the largest number of shares held short as of October 15 experienced a decline in short interest.
Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.
Here’s a look at the seven Nasdaq-traded stocks with the largest number of shares held short as of October 15.
Short interest data for the October 15 settlement date shows that most of the top oil stocks had fewer shares sold short.
Chip stocks all took a hit during the sell-off in mid-October, but the most recent short interest data shows that investors getting ever more focused on individual companies.
If oil prices stabilize and hold the levels analysts anticipate next year, these three oil stocks could see significant rallies.
Seagate Technology reported better-than-expected first-quarter fiscal 2015 results before U.S. markets opened Monday morning.
Petrobras is getting to demonstrate all over again just how bad it is when a nation is under a socialist regime.
Merck reported better-than-expected third-quarter earnings Monday morning.
Many top companies are still set to post third-quarter earnings numbers, and some have additional catalysts that could drive share prices higher this week.
Short interest in the two-week period ending October 15 rose for all four 3D printing companies we follow.
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Monday, October 27, 2014.
Short interest in solar stocks generally rose during the two-week period to October 15. Share prices fell fairly steeply in all four that we have been following.
This week will mark the end of the analyst quiet period for Alibaba, though some analysts have already issued brokerage firm reports.
A 4% rise in Christmas spending may not be enough to substantially lift the revenue at healthy retailers or repair the problems at weaker ones.